key: cord-0820082-q3q4hy8g authors: Zhao, Hongxin; ParryFord, Frances; Dabrera, Gavin; Sinnathamby, Mary; Ellis, Joanna; Dunning, Jake; Osman, Husam; Machin, Nicholas; Pebody, Richard title: Six-year experience of detection and investigation of possible MERS-CoV cases, England, 2012-2018 date: 2020-10-20 journal: Public Health DOI: 10.1016/j.puhe.2020.10.007 sha: 88895a978126cc2072d9af6eb02414836d3571f6 doc_id: 820082 cord_uid: q3q4hy8g Objectives Surveillance for Middle East respiratory syndrome (MERS) has been undertaken in the UK since September 2012. This study describes the surveillance outcomes in England from 2012 to 2018. Study Design This was a descriptive study using surveillance data. Methods Local health protection teams in England report possible MERS cases to the National Infection Service with clinical and laboratory data. Results A total of 1,301 possible MERS cases were identified in the study period. Five cases were laboratory confirmed MERS. The majority of cases had travelled to Saudi Arabia (56.7%) and United Arab Emirates (25.9%). Fifty-four percent of cases were male and 43.7% female. The majority of cases (65.1%) were aged 45 years or over. The number of tests increased in the period following Hajj each year. Laboratory confirmed alternative diagnoses were available for 513 (39.4%) cases; influenza was the most common virus detected (n=255, 52.4%). Conclusions Our study highlights the importance of differential diagnosis of influenza and other respiratory pathogens and early influenza antiviral treatment. Coronaviruses are a large family of viruses that infect animals and humans. 1 Seasonal human coronavirus infections are typically associated with cold or influenza-like illnesses. However, coronaviruses have the potential to cause severe transmissible human disease, as demonstrated by the severe acute respiratory syndrome (SARS) outbreak between 2002-2003 2 and the currently ongoing coronavirus disease 2019 (COVID-19) pandemic in 2020. 3 The Middle East respiratory syndrome coronavirus (MERS-CoV) is a betacoronavirus that was first identified in 2012. 4 The first case of Middle East respiratory syndrome (MERS) to be recognised occurred in the Kingdom of Saudi Arabia (KSA) and was reported in September 2012. 5 In the same month, the UK reported the second infection to be identified globally, in a Qatari national with a travel history to KSA. 4 MERS is not a notifiable disease in the UK, but an enhanced surveillance programme for MERS has been in place in England since 2012, consisting of rapid identification and investigation of possible cases presenting to the UK health system, awareness-raising activities, and implementation of rapid, enhanced respiratory infection prevention and control measures for suspected and confirmed cases. This surveillance is important not only for early detection and treatment of cases, but also to prevent onward spread of the disease, particularly outbreaks in hospital settings, which have been seen elsewhere, especially in the Middle East and the Republic of South Korea. 6 This study describes the results of this national MERS surveillance system in England from September 2012 to September 2018. After the first imported MERS case in the UK was confirmed, 4 in September 2012 this and Yemen (n=3). The clinical and epidemiological characteristics among all investigated patients (where information is available) are summarised in Table 1 . Fever (95.7%) and cough (93.9%) were the most commonly reported symptoms. Pulmonary parenchymal involvement was reported in the majority of investigated patients (79.5%). Acute respiratory distress syndrome (ARDS) and the requirement for mechanical ventilation were reported in 12.9% and 9.4% of cases, respectively, while extracorporeal membrane oxygenation (ECMO) was administered in only terms of requirements for testing and the additional resources required for the appropriate infection prevention and control measures. In addition, 39% of all possible cases had alternative diagnoses identified, mainly influenza, but also other important pathogens such as Legionella species. We must emphasise that influenza and Legionella infections are not only important but also treatable diseases. The main limitation of this study is likely to be the incomplete reporting. Minimum Coronaviruses: an overview of their replication and pathogenesis Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China Director-General's opening remarks at the media briefing on COVID-19 Severe respiratory illness caused by a novel coronavirus Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea A new laboratory-based surveillance system (Respiratory DataMart System) for influenza and other respiratory viruses in England: results and experience from Increase in Legionnaires' disease cases associated with travel to Dubai among travellers from the United Kingdom There are no competing interests.